Isodiol International Inc Share Price Canadian Securities Exchange
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 26.17M 1.52B | Sales 2019 | 22.25M 30.43M 1.77B | Capitalization | 49.96M 68.33M 3.98B |
---|---|---|---|---|---|
Net income 2018 | -36M -49.24M -2.87B | Net income 2019 | -126M -172M -10.04B | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 21.27M 1.24B | Net Debt 2019 | 5.22M 7.14M 416M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 13/02/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Director/Board Member | - | 20/11/18 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |